Funding Rounds
TOLREMO therapeutics Series A (2023, $20M)
TOLREMO therapeuticsDeveloper of small molecules to treat novel drug resistance pathways in cancer therapy.
Summary
Stage: Series A
Raised Amount: $20.40M
Stage: Series A
Raised Amount: $20.40M
